iGMDRD45
Standard Name | CHEMBL | Pubchem CID | KEGG Drug ID | DRUGBANK ID | Drug Status | Drug targets (TTD) | Drug Type |
---|---|---|---|---|---|---|---|
Thalidomide | CHEMBL468 | 5426 | D00754 | DB01041 | Alone | DAP000865 | Small Molecule |
Drug Class:
Acids, CarbocyclicAngiogenesis InhibitorsAngiogenesis Modulating AgentsAnti-Bacterial AgentsAnti-Infective AgentsAntineoplastic AgentsAntineoplastic and Immunomodulating AgentsCarboxylic AcidsCardiotoxic antineoplastic agentsCentral Nervous System DepressantsCytochrome P-450 CYP1A2 SubstratesCytochrome P-450 Enzyme InducersCytochrome P-450 Enzyme InhibitorsGrowth InhibitorsGrowth SubstancesHeterocyclic CompoundsHeterocyclic Compounds, 1-RingHeterocyclic Compounds, 2-RingHypotensive AgentsImidesImmunologic FactorsImmunomodulatory AgentsImmunosuppressive AgentsIsoindolesLeprostatic AgentsMyelosuppressive AgentsNoxaePhthalic AcidsPhthalimidesPiperidinesPiperidonesTeratogensToxic ActionsDrug Targets:
CRBN (Q96SW2)TNF (P01375)NFKB1 (P19838)DNAFGFR2 (P21802)PTGS2 (P35354)Nuclear factor kappa-light-chain-enhancer of activated B cellsORM1 (P02763)Drug Pathways:
Cytokine-cytokine receptor interactionNF-kappa B signaling pathwayHematopoietic cell lineageTNF signaling pathwayDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Gene in drug-gene network: Network Plot
Models in Thalidomide